Kazakstani researchers and Oxford to start the common “Global Healthspan Extension Initiative” project

September 15, 2017

Today, National Laboratory Astana at Nazarbayev University hosts the III International Scientific Conference "Personalized Medicine and Global Health." Well-known researchers of leading universities and centers of near and far abroad, representatives of  the state and commercial organizations of education and public health of Kazakhstan attend this year’s conference. Among guests and speakers  of the conference are Richard Barker, professor and founder of the Center for the Advancement of Sustainable Medical Innovations (CASMI) of the University of Oxford, Avi  Roy, president of the British Foundation for Biogerontology Research (BGRF), Valery Benberin, Head of the Medical Center of the Presidential Administration of Kazakhstan, Ilya Stambler, representative of the International Association for Aging (IAD,Israel), Almaz Sharman, President of the Academy of Preventive Medicine, Adesida Ilesanni, provost, Nazarbayev University and others.

The purpose of the conference is to develop the international cooperation in the joint innovative researches and breakthrough scientific developments in the field of advanced multi-mode biomedicine technologies and to discuss the prospects for creating innovative products based on them to preserve and improve the health of the population of Kazakhstan. Participants will also discuss the possibilities and problems of genomics in general, bioinformatics and the application of new technologies in practice.

According to Zhaxybay Zhumadilov, Director General, National Laboratory Astana, personalized medicine in common will improve medical care, increase its safety and profitability.

 “Personalized medicine is based on the peculiarities of the genetic profile of a particular patient and allows predicting the occurrence of diseases, conducting timely prevention and assuming the active solidary participation of the patient. When a team of specialists, including doctors, bioinformatics, IT specialists, biologists, geneticists, use information about the human genome, molecular markers of specific diseases when targeting therapy, the effect of treatment increases dramatic. We very much hope that the implementation of such approaches in the long term will contribute to significant cost savings, but at the first stage of the introduction of personalized medicine, the health care costs will significantly increase due to the introduction of new high cellular and gene technologies, which is the main barrier for its full implementation,” noted Zhaxybay Zhumadilov.

Within the framework of the conference Richard Barker, Avi Roy, Ilya Stambler and NLA scientists  will hold an official  press briefing, where they tell about joint participation in the Global Healthspan Extension Initiative project, aims to strengthen the foundations for quality longevity. This project is aimed to implement of innovative technologies to expand the boundaries of healthy productive longevity of the population.

To date, the Global Healthspan Extension Initiative has already attracted interest from a number of biotechnology companies from the U.S, UK, Norway, Sweden, France and Germany, which are considering prospects for cooperation in the field of research on quality longevity.